Walmsley, who helped push GSK to focus more exclusively on specialty medicines and oncology, will be succeeded by commercial ...

GSK announced that Luke Miels, the company’s chief commercial officer, will take over as CEO on Jan. 1, replacing Emma ...

GSK's CEO Emma Walmsley will step down at the end of the year and be replaced by insider Luke Miels, the drugmaker said on ...

Commercial chief Luke Miels will take the helm as the pharma company seeks to bring to replenish its product lineup to offset ...

The move caps Walmsley's over eight years in the role that made her the most senior female CEO in the UK. She drove the ...

GSK plc names new CEO as shares rise 3% and maintains a 4% dividend yield; get key insights on GSK stock's outlook and what ...

GSK's CEO Emma Walmsley will step down in December and be replaced by insider Luke Miels, the British drugmaker said on ...

Walmsley, who became CEO of the U.K. drugmaker in 2017 and is due to step down at the end of the year, led GSK through the Covid-19 pandemic, a fight with activist investor Elliott Management, and a ...

Emma Walmsley’s decision to step down as chief executive officer of GSK Plc brings to a close a nearly nine-year tenure, ...

In many countries, tattoos are seen as fashion statements and personal expression, especially among the youth. While reflecting ...

A long-acting HIV jab promises near-perfect protection at just $40 a year, but 115 nations must wait for India's approval of ...